Mouse CD45.1+ cells are either selected or depleted by incubating the sample with a biotin conjugated anti-mouse CD45.1 antibody and then magnetic Streptavidin Nanobeads. The magnetically labeled fraction is retained by the use of a magnetic separator. After collection of the CD45.1+ expressing cells, downstream applications include functional assays, gene expression, phenotypic characterization, etc.